All News

Despite Congressional directives for 30 years to diversify clinical research, the number of studies that include minorities and the diversity of scientists being funded have not improved.

During the last month of 2015, The American Journal of Managed Care asked readers to choose what they thought was the top healthcare story from the year. Options included overall themes from the year and specific events.

An update on where the field of biosimilars currently stands.

What we're reading, January 1, 2016: key healthcare legal battles in 2016; study looks at the safety and outcomes of giving birth outside of the hospital; and a tool helps providers better understand the costs they incur.

A study published in the Journal of the National Cancer Institute found that ease of preparation prior to the screening test is an important determinant of colonoscopy uptake.

In 2014, Forbes said the Massachusetts Health Connector was the worst exchange in the nation.

New data does not support the idea that aspirin has protective qualities and “down-the-road” benefits for breast cancer patients. It may, however, help reduce breast density and improve earlier detection of some breast cancers.

The research has important implications for finding a potential cure for type 1 diabetes.

What we're reading, December 31, 2015: small innovations from doctors and insurers can make a big difference in cutting healthcare costs; WellCare is transitioning its pharmacy benefit management to CVS Health; and US health officials remind Americans to get the flu shot.

Top leaders in healthcare contributed to the anniversary commentary and video series

Most hematologic oncologists have end-of-life discussions with patients with blood cancers too late, according to a new study.

A literature review by researchers at the Abramson Cancer Center has identified a potential use of the cell cycle inhibitor palbociclib in a variety of cancers.

KaloBios Pharmaceuticals has taken multiple hits after CEO Martin Shkreli's arrest on December 17. Now it has filed for Chapter 11 bankruptcy.

The public interest journalism group ProPublica examined records from 2011 through 2014 and found that not only are HIPAA violations common, but they also typically go unpunished.

Studies that provided updates on new drug trials, sessions on value-based care, and the cost of healthcare, were most popular among readers of The American Journal of Managed Care.

Bariatric surgery is becoming a more popular method to address obesity, so physicians and surgeons should be more aware of how time of year affects outcomes.

What we're reading, December 30, 2015: most commonly used generic drugs were cheaper at the end of 2015, meanwhile the FDA has a huge backlog of generic drug applications, and few states are expected to expand Medicaid in 2016.

Stories about therapy, led by updates on Afrezza, were most popular with readers interested in diabetes care.

Puerto Rico’s community health centers face grave challenges because of a lack of funding.

How promoting the penalties of the individual mandates changes the sign-up mix, changing attitudes on women's pelvic health, and the challenges that await Louisiana's new governor as he plans to expand Medicaid.

After having launched a palliative care program in 2014, Cambia Health Solutions is now looking for ways to improve patient access to these tools that can improve a patient's quality of life.

An accompanying editorial says doctors are not irresponsible; they lack access to information about patients'prior overdoses.

The most read articles from The American Journal of Accountable Care explore the future of healthcare delivery as the United States moves to value-based care.

Patient awareness and educational support can improve their attitude as well as prepare them to make better informed decisions on clinical trial participation, a new study has found.

Moffitt Cancer Center said there's nothing wrong with the drug, but a spokesman said the trial is halted for now pending the outcome of the investigation.

What we're reading, December 28, 2015: patients fight for Medicaid coverage of expensive hepatitis C treatment, Express Scripts develops programs to protect insurer's from pricey new drugs, and Republicans divided over Medicaid expansion.

A new study published by the American Cancer Society found that younger colorectal cancer survivors end up spending over $8500 annually in medical expenses and they also experience significantly greater loss of productivity compared with individuals without cancer.

The prior CEO of MannKind attributed slow sales of Afrezza in part to slow reimbursement from insurers.

Study finds healthcare access was of paramount importance to people with chronic conditions and their caregivers.

John B. Watkins, PharmD, MPH, BCPS, pharmacy manager for formulary development at Premera Blue Cross, discussed using cost-effectiveness data for formulary decisions.